Cargando…
2'-Chlorodeoxyadenosine: evaluation of a novel predominantly lymphocyte selective agent in lymphoid malignancies.
2'-Chlorodeoxyadenosine (2CDA) is a purine analogue selectively active against both resting and dividing lymphoid cells. Twenty-one patients with a variety of previously treated lymphoid malignancies received a total of 41 courses of 2CDA (0.1-0.15 mg/kg/day over 7 days continuous intravenous i...
Autores principales: | Hickish, T., Serafinowski, P., Cunningham, D., Oza, A., Dorland, E., Judson, I., Millar, B. C., Lister, T. A., Roldan, A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968218/ https://www.ncbi.nlm.nih.gov/pubmed/8094003 |
Ejemplares similares
-
2-Chlorodeoxyadenosine treatment for cutaneous T-cell lymphoma
por: Sokołowska-Wojdyło, Małgorzata, et al.
Publicado: (2010) -
Similarity of apoptosis induction by 2-chlorodeoxyadenosine and cisplatin in human mononuclear blood cells.
por: Borner, M. M., et al.
Publicado: (1997) -
Cutaneous and laryngopharyngeal papules of xanthoma disseminatum successfully treated with 2-chlorodeoxyadenosine
por: Briones, Naomi F., et al.
Publicado: (2018) -
Modulation of deoxycytidine kinase (dCK) and glycogen synthase kinase (GSK-3β) by anti-CD20 (rituximab) and 2-chlorodeoxyadenosine (2-CdA) in human lymphoid malignancies
por: Al-Katib, Ayad M, et al.
Publicado: (2014) -
2 chlorodeoxyadenosine activity and cross resistance patterns in primary cultures of human hematologic neoplasms.
por: Nagourney, R. A., et al.
Publicado: (1993)